Issue 5, 2015
From the journal:

MedChemComm

Correction: Novel pyrrole derivatives as selective CHK1 inhibitors: design, regioselective synthesis and molecular modeling

Taha M. A. Eldebss,a   Sobhi M. Gomha,a   Mohamed M. Abdullab  and  Reem K. Arafa*cd  

* Corresponding authors

a Department of Chemistry, Faculty of Science, Cairo University, Giza 12613, Egypt

b Research Unit, Saco Pharm. Co., 6th October City, Egypt

c Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, 11562 Giza, Egypt
E-mail: reem.arafa@pharma.cu.edu.eg
Tel: +2 0100 2074028

d Biomedical Sciences Department, University of Science and Technology, Zewail City of Science and Technology, 12588 Giza, Egypt

Abstract

Correction for 'Novel pyrrole derivatives as selective CHK1 inhibitors: design, regioselective synthesis and molecular modeling' by Taha M. A. Eldebss et al., Med. Chem. Commun., 2015, DOI: 10.1039/c4md00560k.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5MD90016F
Article type
Correction
Submitted
23 Mar 2015
Accepted
23 Mar 2015
First published
31 Mar 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2015,6, 977-978

Permissions

Request permissions

Correction: Novel pyrrole derivatives as selective CHK1 inhibitors: design, regioselective synthesis and molecular modeling

T. M. A. Eldebss, S. M. Gomha, M. M. Abdulla and R. K. Arafa, Med. Chem. Commun., 2015, 6, 977 DOI: 10.1039/C5MD90016F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements